ReportWire

Tag: Healthcare

  • Study: health equity an important aspect of improving quality of care provided to children in emergency departments

    Study: health equity an important aspect of improving quality of care provided to children in emergency departments

    [ad_1]

    Newswise — INDIANAPOLIS—A new multi-site study led by Indiana University School of Medicine found increasing pediatric readiness in emergency departments reduces, but does not eliminate, racial and ethnic disparities in children and adolescents with acute medical emergencies.

    The study also involved researchers from Oregon Health and Science University and UC Davis Health. They recently published their findings in JAMA Network Open.

    “Ours is a national study group focused on pediatric emergency department readiness,” said Peter Jenkins, MD, associate professor surgery at IU School of Medicine and first author of the study. “We have been very productive in demonstrating that the more prepared an ED is to take care of kids, the better their chances of survival, and that includes children with traumatic injuries and medical emergencies.”

    “Readiness” can include a variety of factors for an ED, including staffing, materials, training and protocols. Jenkins said the more prepared the hospital, and the more protocols in place, then the more likely a child is to survive a traumatic injury or acute medical emergency. But until now, it was unclear whether children of all races and ethnicities benefit the same from increased levels of readiness.

    “We believe that treatment protocols help to overcome biases and racism because if a child meets criteria, then we do one thing or another,” Jenkins said. “We saw that for kids with traumatic injuries, whose care is largely determined by such protocols, there weren’t significant differences in survival based on race and ethnicity. But for children with medical emergencies, where treatment protocols are often lacking, we found significant disparities in mortality between Black and White kids. Importantly, the higher the level of readiness of the ED, the lower the level of disparity between racial and ethnic groups.”

    Researchers looked at 633,536 pediatric patients at hospitals in 11 states from 2012-2017, making this one of the largest studies of racial and ethnic disparities among children to date.

    “A lot of times when we talk about health equity, people are concerned that improving the condition of one group may result in another group losing out,” Jenkins said. “This study shows the opposite to be true. All groups benefit from improved readiness, and we also have this extra layer of social justice woven into the narrative of improved health care quality. These findings only strengthens the case to provide resources to hospitals so they’re prepared to take care of all sick kids.”

    In the future, the group plans to look at updated surveys of hospitals to determine if there have been changes in pediatric readiness over time. Jenkins said they also plan to promote the importance of health equity into the national platform for pediatric readiness.

    Other lead collaborators include Nathan Kuppermann, MD, MPH from UC Davis and Craig Newgard, MD, MPH from OHSU. Read the full publication in JAMA Network Open.

    About Indiana University School of Medicine

    IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

    [ad_2]

    Indiana University

    Source link

  • Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer

    Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer

    [ad_1]

    By Adria Calatayud

    Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer.
    

    The Swiss consumer-goods company said Monday that it will receive milestone payments and royalties from Stallergenes Greer. The deal was closed upon signing, Nestle said.
    

    

    The sale allows Nestle’s health-science operations to focus on its core strengths and key growth drivers, the unit’s Chief Executive Greg Behar said.
    

    Nestle last year said that it would conduct a strategic review of Palforzia after a slower-than-expected adoption by patients and healthcare professionals.
    

    Write to Adria Calatayud at adria.calatayud@dowjones.com
    

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    J&J Dividend Decision Shows Power of Free Cash Flow
    
			
    J&J Dividend Decision Shows Power of Free Cash Flow
    
			
     [ad_1]
    

    

    

    This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
    

    https://www.barrons.com/articles/johnson-and-johnson-stock-dividend-aristocrats-aa46e2db
    

    

    

    

    

    

    

    

      

    • 
      Order Reprints
      
      
      
            
    
      • 

    • 
    Print Article
      
    
  
      • 

    

    

    

    

    

    
        
    
          
    
            Johnson & Johnson
    
          
    
        
    
       plans to maintain its quarterly dividend at $1.19 a share even after separating its
    
        
    
          
    
            Kenvue
    
          
    
        
    
       over-the-counter drug and pers…
    

    

    

    

     
    

    

     
    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Weight loss surgery outcomes linked to inflammation, study finds
    
			
    Weight loss surgery outcomes linked to inflammation, study finds
    
			
     [ad_1]
    

    

    Newswise — Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.
    

    Published in Psychological Medicine and led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, this is the first study to investigate the links between depression and inflammation in patients with obesity before and after bariatric surgery. The analysis showed a strong relationship between depression and inflammation in obese patients before and after surgery and it indicated that it was increased inflammation, rather than depression that was driving poor weight loss after bariatric surgery. 
    

    Lead author and Clinical Professor of Psychoneuroimmunology at IoPPN, King’s College London, Valeria Mondelli, said: “Our study has important clinical implications as it identifies specific targets for future personalised interventions which could improve physical and mental health outcomes after bariatric surgery. For example, our data showing that increased inflammation predicts lower weight-loss after bariatric surgery suggests that personalised treatments involving approaches that lower inflammation could enable better outcomes after surgery.”
    

    Obesity costs the NHS around £6 billion a year, and this figure is predicted to rise to £9.6 billion per year by 2050. Bariatric surgery physically alters the stomach and/or the bowel to reduce the amount of food people can eat and to reduce the absorption of nutrients: obese patients can lose up to 70 per cent of excess weight after surgery but there is variation in the outcomes. To help patients with obesity and ensure costly treatments are as effective as possible (private bariatric surgery can cost £4,000 to £10,000), it is important to understand the factors that can influence surgery.
    

    Depression and obesity are known to often occur together, and previous research suggests the release of inflammatory proteins as part of the immune response may be a shared disease mechanism that is driving both conditions. To improve the understanding of this relationship and its potential role in obesity and bariatric surgery outcomes, the study investigated the differences in proteins released in the body during inflammation between obese patients with and without depression undergoing surgery.
    

    The 85 participants in the study, enrolled from King’s College Hospital NHS Foundation Trust in south London, were all obese (BMI >35) and part of the ongoing Bariatric Surgery & Depression study.. Levels of proteins released during inflammation, such as C-Reactive Protein (CRP) and cytokines, such as interleukin-6 (IL-6) and interleukin-4 (IL-4), were measured before and after surgery in participants’ blood and tissue.
    

    Before surgery, 41 participants had symptoms of depression that reached the threshold of a clinical diagnosis, while in the remaining 44 participants, the symptoms of depression were below this threshold. The study showed that those with depression had higher levels of the inflammatory proteins CRP and IL-6 in the blood and lower levels of the anti-inflammatory protein IL-4. They also had higher levels of one inflammatory protein in their adipose tissue.
    

    Six months after surgery, the bariatric patients who had depression before surgery continued to have higher levels of IL-6 and CRP in the blood, despite no difference in weight loss between those with and without depression.
    

    Overall bariatric surgery led to weight loss in all patients in line with what is expected , and the majority of patients who previously had depression before surgery also experienced a reduction in their symptoms so that they were no longer considered clinically depressed. Out of 44 patients who had depression before surgery, 29 completed the six-month follow-up and only about one-third (34.5 per cent;10 patients) of those still had clinical depression after surgery. 
    

    Researchers analysed whether measures of inflammation and depression before surgery might be able to predict weight loss and depression after surgery. This showed that higher levels of CRP predicted reduced weight loss at six-month follow-up. However, levels of CRP in the blood before surgery did not predict levels of depression afterwards; instead, this was predicted by depression before surgery and experience of childhood trauma.
    

    First author Dr Anna McLaughlin, Postdoctoral Research Associate at IoPPN, King’s College London, said “Our study is the first to show that inflammation levels in the blood, rather than depression, play a significant role in weight loss outcomes after bariatric surgery. Additionally, our research aligns with previous findings, emphasising that patients with childhood trauma may benefit from more psychological support after surgery. As we move forward, combining inflammation data with clinical insights will be crucial to pinpointing risk factors and improving outcomes for bariatric patients.”
    

     
    

    ‘Peripheral inflammation associated with depression and reduced weight loss: a longitudinal study of bariatric patients’ by McLaughlin, A. P et al was published in Psychological Medicine. Doi: 10.1017/S0033291723002283
    

    After the embargo lifts the paper will be available online: https://doi.org/10.1017/S0033291723002283
    

     
    

    For more information and to receive an embargoed copy of the paper please contact: 
    

      

    • Franca Davenport, Communications and Engagement Manager (part-time), NIHR Maudsley Biomedical Research Centre, [email protected]  Tel: ++ 44 (0) 7976 918968
      • 

    • Alex Booth, Communications and Engagement Manager (part-time), NIHR Maudsley Biomedical Research Centre, [email protected]
      • 

    

     
    

    Notes to editors
    

    The paper is under strict embargo until Friday 1 September 2023 00:01 UK time
    

    The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf
    

     
    

    The National Institute for Health and Care Research (NIHR)
    

    The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:
    

      

    • Funding high quality, timely research that benefits the NHS, public health and social care;
      • 

    • Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
      • 

    • Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
      • 

    • Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
      • 

    • Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
      • 

    • Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.
      • 

    

    NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK Aid from the UK government.
    

    

    

    [ad_2]
    

     King’s College London
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Analysis Reveals Factors Associated With Patients With Sepsis Who Require Mechanical Ventilation
    
			
    Analysis Reveals Factors Associated With Patients With Sepsis Who Require Mechanical Ventilation
    
			
     [ad_1]
    

    

    Newswise — An analysis of 10 years of health data showed that risk factors for needing mechanical ventilation changed for patients with newly diagnosed sepsis as more time passed after onset. 
    

    In the study, 13.5% of patients with a new diagnosis of sepsis required initiation of mechanical ventilation. More than half of these patients required mechanical ventilation within the first 24 hours after sepsis onset, while initiation of mechanical ventilation occurred after 24 hours in 47.4% of patients.
    

    “Factors Associated With Initiation of Mechanical Ventilation in Patients With Sepsis: Retrospective Observational Study” examined 10 years of data from the University of Michigan Medical Center electronic health data warehouse. The analysis included adult patients with sepsis who were not receiving mechanical ventilation at sepsis onset. The study is published in American Journal of Critical Care (AJCC).
    

    Co-author Robert Freundlich, MD, MS, MSCI, is an associate professor, department of anesthesiology, and chief of the anesthesiology informatics research division at Vanderbilt University Medical Center, Nashville, Tennessee. The research was conducted during his research fellowship in critical care at the University of Michigan, Ann Arbor.
    

    “Requiring mechanical ventilation is often a pivotal point for patients with sepsis, and their risk of respiratory failure may vary with time,” he said. “Identifying patients at high risk and implementing targeted interventions in a timely manner has the potential to significantly improve outcomes.”
    

    A total of 35,020 patients met sepsis criteria, and 28,747 patients were eligible for inclusion after exclusion criteria were applied. The dataset spanned July 10, 2009, to Sept. 7, 2019.
    

    Of all eligible patients, 3,891 (13.5%) required mechanical ventilation within 30 days after sepsis onset. Of these, 2,046 (52.6%) required mechanical ventilation within 24 hours of diagnosis. Mechanical ventilation was subsequently initiated for 441 (11.3%) patients from one to two days after sepsis onset, and for 312 (8.0%) patients from two to three days following diagnosis. The remaining 1,092 (28.1%) experienced late respiratory failure or required mechanical ventilation three to 30 days after diagnosis.
    

    Patients requiring mechanical ventilation had higher baseline illness severity and a higher prevalence of 27 of the 35 comorbidities on the Elixhauser Comorbidity Index, which measures overall severity of comorbidities.
    

    They also had a higher in-hospital mortality rate (21%) than patients who did not require mechanical ventilation (7%). Further analysis revealed that of the patients who received mechanical ventilation before but not after sepsis onset, only 35 (4% of 822) died prior to hospital discharge.
    

    Factors that were independently associated with an increased likelihood that mechanical ventilation would be needed included race, systemic inflammatory response syndrome (SIRS) score, Sequential Organ Failure Assessment (SOFA) score and congestive heart failure. Risks decreased with time for the SOFA score and congestive heart failure and varied with time for four comorbidities and three culture results.
    

    The researchers recommend future proactive studies focus on the effects of fluid resuscitation and other processes of care on the need for mechanical ventilation in this patient population. The use of noninvasive ventilation and high-flow nasal cannula may also impact the need for intubation and mechanical ventilation and should be evaluated.
    

    To access the article and full-text PDF, visit the AJCC website at www.ajcconline.org.
    

    About the American Journal of Critical Care: The American Journal of Critical Care (AJCC), a bimonthly scientific journal published by the American Association of Critical-Care Nurses, provides leading-edge clinical research that focuses on evidence-based-practice applications. Established in 1992, the award-winning journal includes clinical and research studies, case reports, editorials and commentaries. AJCC enjoys a circulation of about 130,000 acute and critical care nurses and can be accessed at www.ajcconline.org.
    

    About the American Association of Critical-Care Nurses: For more than 50 years, the American Association of Critical-Care Nurses (AACN) has been dedicated to acute and critical care nursing excellence. The organization’s vision is to create a healthcare system driven by the needs of patients and their families in which acute and critical care nurses make their optimal contribution. AACN is the world’s largest specialty nursing organization, with about 130,000 members and nearly 200 chapters in the United States.
    

    American Association of Critical-Care Nurses, 27071 Aliso Creek Road, Aliso Viejo, CA 92656; 949-362-2000; www.aacn.org; facebook.com/aacnface; twitter.com/aacnme
    

    

    

    [ad_2]
    

     American Association of Critical-Care Nurses (AACN)
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Higher Prostate Cancer Rates Topic of Expert Panel
    
			
    Higher Prostate Cancer Rates Topic of Expert Panel
    
			
     [ad_1]
    

    

    September is prostate cancer awareness month, so the American College of Surgeons is teaming up with their urologist colleagues to promote better prevention for men at risk for this growing category of cases. A recent report from the American Cancer Society detailed the alarming increase in rates of late-diagnosed cases. With that in mind, this panel will address proper screening and prevention and discuss the higher risks for minority groups, reluctance to discuss the issue, and advice for both patients and practitioners. 
    

     
    

    What: Expert panel from the American College of Surgeons will address proper screening and prevention of prostate cancer
    

    When: September 11, 2023, at 12 PM EDT
    

    Who: Panelists to be announced
    

    Where: Newswise Live Events Zoom Room (link will be given once you register)
    

    Details:
    

    A recent report from the American Cancer Society detailed the alarming increase in rates of late-diagnosed cases of prostate cancer. With Prostate Cancer Awareness month in September, this panel will address proper screening and prevention and discuss the higher risks for minority groups, reluctance to discuss the issue, and advice for both patients and practitioners.
    

    Media register to attend and/or receive transcript and video
    

    

    

    [ad_2]
    

     Newswise
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
    
			
    Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
    
			
     [ad_1]
    

    

    By David Sachs
    

    Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.
    

    The Swiss pharmaceutical company said the results, from a Phase 3 study of 257 people which compared the treatment with platinum-based chemotherapy, met its primary goal of disease-free survival in people with early-stage non-small cell lung cancer. About half of people with this type of lung cancer experience a recurrence of the disease after surgery, Roche said.
    

    

    Roche said that it found no unexpected safety issues and will submit the data to global health authorities.
    

    Write to David Sachs at david.sachs@wsj.com
    

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Johnson & Johnson Maintains Dividend After Kenvue Spinout
    
			
    Johnson & Johnson Maintains Dividend After Kenvue Spinout
    
			
     [ad_1]
    

    

    
        
    
          
    
            Johnson & Johnson
    
          
    
        
    
       on Wednesday issued new financial guidance after spinning out the consumer-health company
    
        
    
          
    
            Kenvue
    
          
    
        
    
       While its earnings and sales projections were lowered on an absolute basis, the company is maintaining its dividend and expects to increase its revenue at a faster pace. 
    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    AI can predict certain forms of esophageal and stomach cancer
    
			
    AI can predict certain forms of esophageal and stomach cancer
    
			
     [ad_1]
    

    

    
BYLINE: Jina Sawani, Michigan Medicine 
    

    Newswise — In the United States and other western countries, a form of esophageal and stomach cancer has risen dramatically over the last five decades. Rates of esophageal adenocarcinoma, or EAC, and gastric cardia adenocarcinoma, or GCA, are both highly fatal.
    

    However, Joel Rubenstein, M.D., M.S., a research scientist at the Lieutenant Colonel Charles S. Kettles Veterans Affairs Center for Clinical Management Research and professor of internal medicine at Michigan Medicine, says that preventative measures can be a saving grace.
    

    “Screening can identify pre-cancerous changes in patients, Barrett’s esophagus, which is sometimes diagnosed in individuals who have long-term gastroesophageal reflux disease, or GERD,” he said.
    

    “When early detection occurs, patients can take additional steps to help prevent cancer.”
    

    While current guidelines already consider screening in high-risk patients, Rubenstein notes that many providers are still unfamiliar with this recommendation.
    

    “Many individuals who develop these types of cancer never had screening to begin with,” he said.
    

    “But a new automated tool embedded in the electronic health record holds the potential to bridge the gap between provider awareness and patients who are at an increased risk of developing esophageal adenocarcinoma and gastric cardia adenocarcinoma.”
    

    Rubenstein and a team of researchers used a type of artificial intelligence to examine data regarding EAC and GCA rates in over 10 million U.S. veterans.
    

    Their findings were published in Gastroenterology. 
    

    Rubenstein and his team developed and tested the Kettles Esophageal and Cardia Adenocarcinoma predictioN tool, called K-ECAN for short.
    

    “K-ECAN uses basic information already readily available in the EHR, like patient demographics, weight, previous diagnoses and routine laboratory results, to determine an individual’s risk of developing esophageal adenocarcinoma and gastric cardia adenocarcinoma,” said Rubenstein.
    

    “We developed a prior tool, M-BERET, over a decade ago for identifying patients with Barrett’s esophagus. However, that tool requires measuring patients’ hip and waist circumferences, which is not something that routinely occurs. In addition, providers must remember to use the corresponding website to calculate their patient’s risk when using this tool.”
    

    To alleviate this burden, Rubenstein said that they “envisioned harnessing the large amount of data already present in the EHR, as well as presenting their patients’ risk to their providers at opportune times,” such as when an individual is due for a colorectal screening or refilling an acid reducing prescription medication.
    

    According to Rubenstein, K-ECAN is more accurate than published guidelines or previously validated prediction tools and can “accurately predict cancer at least three years prior to a diagnosis.”
    

    “Symptoms of GERD, like heartburn, are an important risk factor for esophageal adenocarcinoma,” he said.
    

    “But most people with GERD symptoms will never develop esophageal adenocarcinoma and gastric cardia adenocarcinoma. In addition, roughly half of the patients with this form of cancer never experienced prior GERD symptoms at all. This makes K-ECAN particularly useful because it can identify people who are at elevated risk, regardless of whether they have GERD symptoms or not.”
    

    Akbar Waljee, M.D., M.Sc., professor in the Departments of Learning Health Sciences and Internal Medicine and senior author on the study, adds that this research wouldn’t be possible without a collaborative effort.
    

    “This publication, which leveraged invaluable data from millions of U.S. veterans, was made possible through the dedicated efforts of numerous staff members at our VA Health Services Research & Development Center of Innovation, as well as through collaborative partnerships between the VA Center for Clinical Management Research, Michigan Medicine, the University of Michigan Department of Statistics, and members of U-M’s Institute for Healthcare Policy & Innovation and E-Health & Artificial Intelligence, or e-HAIL. This exemplifies the power of team science, data and machine learning to improve cancer prevention.”
    

    Incorporating this artificial intelligence tool into the EHR could alert providers with an automated notification regarding which patients are at an increased risk of developing esophageal adenocarcinoma and gastric cardia adenocarcinoma.
    

    And Rubenstein says that this can significantly decrease the burden of these cancers
    

    “Our devoted team was able to use sophisticated machine learning tools to develop this unique tool, and we are very excited that this could potentially lead to increased screening and a decrease in preventable deaths. We look forward to conducting additional work validating K-ECAN for use outside of the VA.”
    

    

    

    [ad_2]
    

     Michigan Medicine – University of Michigan
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Susan McMullan Receives AANA’s 44th Annual Helen Lamb Outstanding Educator Award
    
			
    Susan McMullan Receives AANA’s 44th Annual Helen Lamb Outstanding Educator Award
    
			
     [ad_1]
    

    

    Newswise — Rosemont, Ill. (AANA) – The American Association of Nurse Anesthesiology (AANA) presented Certified Registered Nurse Anesthetist (CRNA) Susan McMullan, PhD, CRNA, CHSE, FAANA, FAAN with the 44th Annual Helen Lamb Outstanding Educator Award during its 2023 Annual Congress, August 18-22, in Seattle.
    

    The Helen Lamb Outstanding Educator Award, established in 1980, is presented to a CRNA who has made a significant contribution to the education of nurse anesthetists. The award recognizes the individual’s commitment to the profession of nurse anesthesiology and to the advancement of educational standards that further the art and science of anesthesiology and result in high-quality patient care.
    

    Throughout her 35 years as a CRNA, including 12 years in nurse anesthesia education, McMullan has made a tremendous contribution to the education of CRNAs and a meaningful impact on the profession of  nurse anesthesiology.
    

    McMullan is an associate professor and director of the BSN-DNP Pathway in Nurse Anesthesia at the University of Alabama at Birmingham (UAB). Since joining the UAB Nurse Anesthesia Program (NAP), McMullan has made significant improvements in making a positive impact on the nurse anesthesia workforce in the southeast. Under her leadership, the UAB NAP successfully transitioned from a Master of Science in Nursing (MSN) to the Bachelor of Science (BSN)-Doctor of Nursing Practice (DNP) program of study, graduating the first doctorally prepared class of nurse anesthetists in 2020 during the height of the COVID-19 pandemic. McMullan was also key in increasing the number of CRNAs in Alabama during a critical workforce shortage by doubling class cohort size and securing additional clinical training sites.
    

    In addition to improving the CRNA workforce numbers, McMullan is passionate about increasing the diversity of the CRNA workforce. Due to her leadership and dedication to diversity, equity, and inclusion efforts, she participated in the inaugural Leadership Excel and Achievement Program, working with Case Western University to increase and sustain diversity in the nurse anesthesiology profession.
    

    McMullan is a key contributor to advancing nurse anesthesiology education standards at the national level through her work on the Executive Committee of the National Board for Certification Recertification of Nurse Anesthetists (NBCRNA). She is serving her second three-year term in the current role of vice-president and will become president in fall 2023. Her work with the NBCRNA has been instrumental in developing policies to include research-based, innovative methods for improved certification/recertification processes and lifelong learning for CRNAs, ensuring patients continue to receive the high quality, safe, and cutting-edge care they deserve. Among her other honors, McMullan was recently inducted as a Fellow of the AANA and American Academy of Nursing.
    

    “Like the leader that came before her, Helen Lamb, Dr. Susan McMullan unambiguously represents everything a nurse anesthetist should aspire to be,” her nomination said. “She is passionate about and devoted to uplifting the nurse anesthesia profession through educating and cultivating nurse anesthesia leaders.”
    

    “I am so honored to follow in Helen Lamb’s footsteps and continue her tradition of training nurse anesthetists at our medical center.  It has truly been an honor and one of the greatest achievements and highlights of my life, “said McMullan of the award.
    

    McMullan is a graduate of Rutgers College of Nursing, Rutgers, the State University of New Jersey, with a PhD in nursing science and a Master of Nursing in nurse anesthesia from Rush University in Chicago. She received her bachelor’s degree in nursing from The University of Michigan in Ann Arbor.
    

    

    

    [ad_2]
    

     American Association of Nurse Anesthesiology
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    J&J Investors Can Convert Only a Fraction of Shares Into Kenvue Stock
    
			
    J&J Investors Can Convert Only a Fraction of Shares Into Kenvue Stock
    
			
     [ad_1]
    

    

    
        
    
          
    
            Johnson & Johnson
    
          
    
        
    
       $35 billion exchange offer for
    
        
    
          
    
            Kenvue
    
          
    
        
    
       that expired last Friday was substantially oversubscribed. The result is that participating J&J holders will be able to convert only a fraction of their shares for Kenvue stock.
    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    AANA Launches MOTION Career Exploration Platform to Empower CRNAs with Better Career Choices
    
			
    AANA Launches MOTION Career Exploration Platform to Empower CRNAs with Better Career Choices
    
			
     [ad_1]
    

    

    Newswise — ROSEMONT, Ill. – The American Association of Nurse Anesthetists (AANA) has launched its new interactive career exploration platform, MOTION, to assist each of AANA’s nearly 61,000 members in making informed career choices.
    

    MOTION is a cutting-edge, map-based career-exploration platform that is purpose-built to assist CRNAs in making well-informed career decisions and locate the best opportunities for personal and professional growth. The platform empowers members to take control of their job search by providing them with the most comprehensive database of virtually every CRNA employer location in the United States.
    

    “At AANA, our mission is to be tireless advocates for all Certified Registered Nurse Anesthetists (CRNAs), supporting their careers and enriching their lives and those of their families,” said Chief Executive Officer Bill Bruce. “As the healthcare landscape evolves, we recognize the need to equip our members with better tools to navigate their career paths. MOTION will provide our members with the resources they need to thrive in their profession.”
    

    Created by MedGeo Ventures, MOTION was born from the belief that the right career move can be transformative, not just for pay scale and hours, but for every aspect of life. CRNAs, upon login, will be presented with a map that features CRNA employer locations. Each location on the map will be flagged and searchable as one of three designations:
    

      

    • INACTIVE SITES: Employers have the option to add branding and update the information for their practice sites and providers at any time, free of charge.
      • 

    • NETWORKING SITES: Employers can upgrade their sites to “networking” status to build a talent pipeline or hire opportunistically. The Networking Sites offer detailed employer information, including contact information.
      • 

    • HIRING SITES: Employers can upgrade to hiring sites, allowing them to identify locations with active job openings. Hiring Sites provide all the features of Networking Sites, plus unlimited job postings for that location.
      • 

    

    Additional features unique to AANA’s MOTION platform include map layers of community information such as housing costs and commute times; employer messaging to directly engage with employers before submitting an application; the ability to follow a site or entire market to get notifications of material changes; and AANA career liaisons to assist members with career option research and facilitate member referrals to employers.
    

    MedGeo, a partially held subsidiary of AANA, strives to equip members of the healthcare profession with better tools to navigate their career paths.
    

    “We are living through a unique time in the history of our field, and we are committed to supporting CRNAs with a platform that delivers more data and better ways to connect with employers,” said MedGeo Co-Founder, Jarod Collins.
    

     
    

    About MedGeo
    

    MedGeo is a map-based career exploration platform that’s purpose-built for medical association members. Our white-labeled, interactive experience gives associations more ways to improve the member experience with advanced search filters, robust comparative data, and an enjoyable search experience for job seekers.
    

     
    

    About AANA
    

    Founded in 1931 and located in Rosemont, Ill., and Washington, D.C., the American Association of Nurse Anesthesiology (AANA) is the professional organization representing nearly 61,000 Certified Registered Nurse Anesthetists (CRNAs) and student registered nurse anesthetists across the United States. As advanced practice registered nurses, CRNAs are anesthesia experts who administer more than 50 million anesthetics to patients in the United States each year and are the primary providers of anesthesia care in rural America. CRNAs represent more than 80% of the anesthesia providers in rural counties. For more information, visit www.aana.com.
    

     
    

     
    

    

    

    [ad_2]
    

     American Association of Nurse Anesthesiology
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Remote learning during pandemic aids medical students with disabilities
    
			
    Remote learning during pandemic aids medical students with disabilities
    
			
     [ad_1]
    

    

    
BYLINE: Patricia DeLacey 
    

    Newswise — Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows.
    

    The proportion of students reporting attention deficit hyperactivity disorder or chronic health and/or psychological disabilities has increased between 2015 and 2021.
    

    Despite the increase in medical students reporting these conditions, the requests for more inclusive preclinical testing accommodations, like extra time for test completion or a less distracting environment, decreased during the pandemic between 2019 and 2021.
    

    According to authors of the new research letter in JAMA Network Open, the remote curriculum delivery during the pandemic may have allowed students to create an optimal learning and testing environment, decreasing the need for accommodation.
    

    “Medical education was at its most flexible during COVID,” said Lisa Meeks, Ph.D., clinical associate professor of learning health sciences and family medicine at the University of Michigan Medical School.
    

    She adds that this could have reduced the need for testing accommodations, but it is unclear whether the need for accommodations will rise again after the recent return to in-person lectures and testing.
    

    Documenting the rise
    

    The study results are part of a long-term research project led by Meeks that follows the prevalence of medical students in the United States who disclose disabilities to their respective schools.
    

    This study on disability disclosure in medicine was the first large scale study of its kind, encompassing all types of disability, including psychological, learning, sensory, physical and chronic health conditions.
    

    Since 2015, researchers have seen an increase of medical students reporting a disability to their institution from 2.8% in 2015 to 4.7% in 2019, and to 5.9% in 2021.
    

    When asked to describe why we see such large increases in the population of medical students with disabilities, Meeks posited that “growth in this population could mean that we are reducing bias and stigma, and therefore people who were already in medicine are more willing to disclose.”
    

    “It could also mean that our research sparked a conversation to change policies, which then led to individuals with disabilities who didn’t think they could make it in medical school choosing to apply to these schools.”
    

    Doctors with disabilities improve patient care
    

    According to Meeks, there is still significant work to be done to increase the representation of doctors with disabilities in medicine.
    

    Only 5.9% of medical school students report a disability, but 27% of adults in the U.S. currently live with some type of disability.
    

    As the population ages, this number is expected to increase.
    

    “Physicians in the U.S. and many other countries report that they do not feel confident in their ability to provide equal quality of care to patients with disabilities as they provide to patients without disabilities,” said Karina Pereira-Lima, Ph.D., a research fellow in the Michigan Medicine neurology department.
    

    “The inclusion of professionals with disabilities in medicine can greatly improve the care for patients with disabilities and the health of the population overall.”
    

    Retaining medical trainees with disabilities
    

    Increasing the number of physicians with disabilities requires both the recruitment and retention of medical trainees.
    

    “Anonymous research with medical trainees with disability shows that about one in every five medical students and more than half of resident physicians do not request accommodations when they need them,” said Pereira-Lima.
    

    The two main reasons for not requesting needed accommodation were fear of stigma or bias and lack of a clear institutional process.
    

    “Program access, or simply having the ability to access accommodations should they need them, improves medical trainees with disabilities performance in relation to testing and patient care. It also reduces the likelihood of reporting depressive symptoms or burnout,” added Pereira-Lima.
    

    Meeks advocated for “standardization in support for students with disabilities in medical education.”
    

    “Medical education strives for parity and continuity between medical schools, but when it comes to disability services and reasonable accommodations, there’s no standardization whatsoever,” said Meeks.
    

    “One school could have an incredible specialized disability support services with a qualified disability resource professional running the office, while another school does not have a specialized disability support service at all.”
    

    ‘A wave of change’
    

    The team notes that addressing the second common barrier to attaining needed disability accommodations and fear of stigma or bias requires a continued culture shift in medicine.
    

    “Disability is still incredibly stigmatized, and ableism is rampant in medicine and medical education. At the same time, I think the work from our lab, the Association of American Medical Colleges, the Accreditation Council for Graduate Medical Education and others in medicine started a wave of change that is extraordinarily strong,” said Meeks.
    

    This work is bolstered by the matriculation of individuals that Meeks calls the post Americans with Disabilities Act generation into medical school.
    

    “This generation has a lot of disability pride. They’ve had accommodations their entire lives, they know the law, they know their rights and they’re not ashamed of being disabled,” said Meeks.
    

    Next steps
    

    As this long term study continues, the research team plans to assess how other identities interact with the disability identity.
    

    “People with disabilities have different racial and ethnic backgrounds, sexual orientations and socio-economic statuses. We want to learn more about how the interaction between these different identities impacts the performance and mental health of medical students with disabilities,” said Pereira-Lima. 
    

    Meeks adds that thanks to new funding from the Robert Wood Johnson Foundation the DocsWithDisabilities team is doing just that.
    

    “We’re also developing methods to measure the efficacy of accommodations. We need to do more research on the quality of received accommodations and how easy the process was for them to receive the accommodations they needed” added Pereira-Lima.
    

    “Investing in a culture that acknowledges disability as a valuable form of diversity will improve patient care.”
    

    

    

    [ad_2]
    

     Michigan Medicine – University of Michigan
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Novartis Sets Sandoz Spinoff Date for Oct. 4
    
			
    Novartis Sets Sandoz Spinoff Date for Oct. 4
    
			
     [ad_1]
    

    

    By Adria Calatayud
    

    Novartis said the planned spinoff of its Sandoz generic pharmaceuticals and biosimilars business is expected to occur on or around Oct. 4.
    

    The Swiss pharmaceutical giant said Friday that the separation will take place through a proposed distribution of Sandoz shares to its existing shareholders. Novartis shareholders will get one Sandoz shares for every five Novartis shares held and one Sandoz American depositary receipts–or ADRs–for every five Novartis ADRs, the company said.
    

    

    Novartis had previously said it expected the spinoff to happen early in the fourth quarter.
    

    The Sandoz spinoff remains subject to approval by Novartis’s shareholders. Novartis has scheduled an extraordinary general meeting for Sept. 15 to vote on the proposed distribution of Sandoz shares and a reduction in its own share capital in connection with the spinoff, it said.
    

    Following the separation, Sandoz would be listed in SIX Swiss Exchange, with an ADR program in the U.S., Novartis said.
    

    Write to Adria Calatayud at adria.calatayud@dowjones.com
    

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.
    
			
    J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.
    
			
     [ad_1]
    

    

    
        
    
          
    
            Johnson and Johnson
    
          
    
        
    
       $40 billion exchange offer for shares in
    
        
    
          
    
            Kenvue
    
          
    
        
    
       is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to swap only a portion of their J&J stock. 
    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    J&J Investors Must Decide If They Want Kenvue Stock
    
			
    J&J Investors Must Decide If They Want Kenvue Stock
    
			
     [ad_1]
    

    

    

    This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
    

    https://www.barrons.com/articles/kenvue-jnj-stock-price-exchange-offer-e85c3c90
    

    

    

    

    

    

    

    

      

    • 
      Order Reprints
      
      
      
            
    
      • 

    • 
    Print Article
      
    
  
      • 

    

    

     
    

    

     
    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Exor Buys 15% Stake in Philips
    
			
    Exor Buys 15% Stake in Philips
    
			
     [ad_1]
    

    

    By Joe Hoppe
    

    Exor and Royal Philips jointly said that they have entered a relationship agreement, with Exor picking up a 15% stake in Philips for an undisclosed sum, but worth around 2.58 billion euros ($2.82 billion).
    

    

    Investment company Exor, which holds stakes in a number of companies such as car makers Ferrari and Stellantis, said Monday that its investment is fully supportive of Dutch health-technology company Philips’ leadership, strategy and value creation potential, and gives it the ability to nominate one member to Philips’ supervisory board.
    

    As of Friday’s closing, Philips had a market cap of around EUR17.18 billion.
    

    Exor said it was committed to being a long-term minority investor, and while it doesn’t plan to buy more shares in Philips in the short-term, over time the agreement allows for Exor to increase its participation to a maximum limit of 20% of Philips’ outstanding share capital.
    

    “Exor’s investment in Philips, their long-term outlook and increased focus on healthcare and technology, fit well with our strategy and substantial value creation potential,” Philips Chief Executive Roy Jakobs said.
    

    Write to Joe Hoppe at joseph.hoppe@wsj.com
    

    

    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Home Depot, Target, and More to Watch This Week
    
			
    Home Depot, Target, and More to Watch This Week
    
			
     [ad_1]
    

    Home Depot, Target, Cisco, Deere, Walmart, and More Stocks to Watch This Week
    

    [ad_2]
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Andrew Chang joins UChicago Medicine as Chief Marketing Officer
    
			
    Andrew Chang joins UChicago Medicine as Chief Marketing Officer
    
			
     [ad_1]
    

    

    Newswise — Andrew “Andy” Chang has been selected as UChicago Medicine’s new Vice President, Chief Marketing Officer. He joins the health system August 28.
    

    Chang’s robust marketing career has spanned numerous industries during the past two decades. He comes to UChicago Medicine from VillageMD, which provides primary, multispecialty and urgent care services across the U.S. As vice president of marketing at VillageMD, Chang spent the past three years overseeing the company’s marketing strategy, brand, physician outreach, analytics and marketing technology platforms. Before joining VillageMD, Chang served as executive director of marketing and physician outreach at Piedmont Healthcare, a 22-hospital system based in Atlanta. Prior to his work in healthcare, he led marketing efforts at the real estate firm Stan Johnson Company, various divisions of shipping company UPS and AirTran Airways.
    

    At UChicago Medicine, Chang will lead the health system’s Marketing Department and will develop and maintain strategic, cohesive, and successful brand and digital marketing strategies. He brings an innovative, analytical and data-focused approach to marketing and will move UChicago Medicine to the forefront of healthcare marketing. He will align marketing messaging for UChicago Medicine’s evolving clinical enterprise. He also will work to grow the business by promoting the system’s world-class network, medical care and research enterprise.
    

    Chang has a master’s degree in business administration from Wake Forest University and a bachelor’s degree in molecular and cell biology from the University of California, Berkeley.
    

    

    

    [ad_2]
    

     University of Chicago Medical Center
    

    Source link 
    

    
			
    
		
    
		
	
  • 
		
		
    
			
    Krista Curell named UChicago Health System COO
    
			
    Krista Curell named UChicago Health System COO
    
			
     [ad_1]
    

    

    Newswise — Krista Curell has been appointed Executive Vice President and Chief Operating Officer for the University of Chicago Health System, where she will work to ensure a coordinated and comprehensive approach that supports the organization’s future growth.
    

    Working collaboratively with the leaders at the various sites, Curell will guide day-to-day operations across the UChicago Medicine health system and focus on optimizing and fully integrating operations at the care sites, including Ingalls Memorial Hospital.
    

    A nurse and an attorney, Curell has dedicated her professional career to the University of Chicago Medical Center since 2001.
    

    Her new role builds on her work as Chief Transformation and Integration Officer, a position she has had since March 2021, and her more recent additional responsibilities as Chief Administration Officer. In these capacities she has created integrated structures for the departments of Risk Management, Patient Safety & Quality Performance Improvement, Patient Experience, Compliance, Human Resources and other shared services.
    

    Curell’s credentials also include her experience and demonstrated strategic leadership over the enterprise’s Emergency Operations Division, serving as Incident Commander of the Hospital Incident Command Structure over the past decade.
    

    

    

    [ad_2]
    

     University of Chicago Medical Center
    

    Source link